Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8332-7. doi: 10.1073/pnas.1422104112. Epub 2015 Jun 22.

Abstract

Genetic factors are important determinants of the onset and progression of diabetes mellitus. Numerous susceptibility genes for type 2 diabetes, including potassium voltage-gated channel, KQT-like subfamily Q, member1 (KCNQ1), have been identified in humans by genome-wide analyses and other studies. Experiments with genetically modified mice have also implicated various genes in the pathogenesis of diabetes. However, the possible effects of the parent of origin for diabetes susceptibility alleles on disease onset have remained unclear. Here, we show that a mutation at the Kcnq1 locus reduces pancreatic β-cell mass in mice by epigenetic modulation only when it is inherited from the father. The noncoding RNA KCNQ1 overlapping transcript1 (Kcnq1ot1) is expressed from the Kcnq1 locus and regulates the expression of neighboring genes on the paternal allele. We found that disruption of Kcnq1 results in reduced Kcnq1ot1 expression as well as the increased expression of cyclin-dependent kinase inhibitor 1C (Cdkn1c), an imprinted gene that encodes a cell cycle inhibitor, only when the mutation is on the paternal allele. Furthermore, histone modification at the Cdkn1c promoter region in pancreatic islets was found to contribute to this phenomenon. Our observations suggest that the Kcnq1 genomic region directly regulates pancreatic β-cell mass and that genomic imprinting may be a determinant of the onset of diabetes mellitus.

Keywords: Kcnq1; imprinting; pancreatic β-cells.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Cyclin-Dependent Kinase Inhibitor p57 / genetics*
  • Cyclin-Dependent Kinase Inhibitor p57 / metabolism
  • Epigenesis, Genetic*
  • Gene Expression
  • Genomic Imprinting / genetics
  • Glucose / pharmacology
  • Glucose Tolerance Test
  • Immunoblotting
  • Inheritance Patterns
  • Insulin / blood
  • Insulin / metabolism
  • Insulin Secretion
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • KCNQ1 Potassium Channel / genetics*
  • KCNQ1 Potassium Channel / metabolism
  • Male
  • Mice, Knockout
  • Mutation*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Cdkn1c protein, mouse
  • Cyclin-Dependent Kinase Inhibitor p57
  • Insulin
  • KCNQ1 Potassium Channel
  • Kcnq1 protein, mouse
  • Glucose